Drug Profile
Hepatitis A vaccine inactivated - GSK
Alternative Names: Havrix; Havrix Junior®; Havrix Monodose®Latest Information Update: 02 Aug 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Hepatitis A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis A
Most Recent Events
- 23 Nov 2006 SBL Vaccin AB has been acquired by Crucell
- 21 Oct 2005 The US FDA has approved the expanded use of the Hepatitis A vaccine inactivated in children aged 12 months and older
- 26 Aug 2003 PowderJect Pharmaceuticals has been acquired by Chiron Corporation